<DOC>
	<DOCNO>NCT02256267</DOCNO>
	<brief_summary>The aim two-period study compare much study drug get blood stream give single oral dose give single oral dose combination rifampin ( Food Drug Administration [ FDA ] approve antibiotic use treat tuberculosis , bacterial infection mainly affect lung , infection ) . Each participant complete study period . The study last 34 day . Screening require within 28 day study drug give .</brief_summary>
	<brief_title>A Study LY2835219 Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Overtly healthy sterile male surgically sterile female postmenopausal female Have body mass index ( BMI ) 18 32 kilogram per meter square ( kg/m^2 ) Have participate clinical trial involve investigational product within last 30 day Have abnormality 12lead electrocardiogram ( ECG ) , opinion investigator , increase risk associate participate study Have abnormal blood pressure Show evidence human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C Have donate blood 500 milliliter ( mL ) within last month Have use intend use overthecounter prescription medication include herbal medication within 7 day prior dose study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>